DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
If you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...
Investors who lost money on TransMedics Group, Inc.(TMDX) should contact Levi & Korsinsky about pending Class Action - TMDX
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
TMDX Shareholders With Large Losses Should Contact Robbins LLP For Information About The Securities Class Action Against Transmedics Group, Inc.
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
TransMedics: Big Growth And Operational Advantages, Buy This Leading Medical Player
TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...
Zacks.com on MSN1d
Curious about TransMedics (TMDX) Q4 Performance? Explore Wall Street Estimates for Key Metrics
In its upcoming report, TransMedics (TMDX) is predicted by Wall Street analysts to post quarterly earnings of $0.18 per share, reflecting an increase of 50% compared to the same period last year.
Van ECK Associates Corp Boosts Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX)
Van ECK Associates Corp grew its holdings in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 102.3% in the fourth ...
Business Wire10d
TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...
Business Wire7d
TMDX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of TransMedics Group, Inc. Investors
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...
TransMedics to Present at Upcoming March Investor Conferences
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...
Morningstar3d
TMDX CLASS ACTION DEADLINE: TransMedics Group, Inc. Investors with Losses are Notified of Ongoing Lawsuit – Contact BFA Law by April 15 Deadline
NEW YORK, Feb. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX ...
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of “Moderate Buy” from Analysts
TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ...